Skip to main content
Apollo Hospitals Enterprises Ltd. logo

Apollo Hospitals Enterprises Ltd. — Investor Relations & Filings

Ticker · APOLLOHOSP ISIN · INE437A01024 BSE.NS Human health and social work activities
Filings indexed 1,914 across all filing types
Latest filing 2023-02-14 Regulatory Filings
Country IN India
Listing BSE.NS APOLLOHOSP

About Apollo Hospitals Enterprises Ltd.

https://www.apollohospitals.com/

Apollo Hospitals Enterprises Ltd. is an integrated healthcare provider operating a vast network of multi-specialty hospitals, primary care facilities, and diagnostic centers. The organization offers specialized clinical services in fields such as cardiology, oncology, neurology, orthopedics, and multi-organ transplants. Its business model encompasses an extensive retail pharmacy chain and a digital health ecosystem, Apollo 24/7, providing teleconsultations and home-based care. The company leverages advanced medical infrastructure, including robotic surgery systems and proton therapy, to provide complex tertiary care. Serving both domestic and international patients, the company integrates preventive health screenings, emergency medical services, and clinical research. The focus remains on delivering comprehensive medical solutions through a vertically integrated model that spans from primary clinics to advanced quaternary care centers.

Recent filings

Filing Released Lang Actions
as per annexure enclosed
Regulatory Filings Classification · 95% confidence The document is a disclosure under SEBI Listing Regulations specifically citing Regulations 52(7), 52(7A), and 54(3) related to Unsecured Non Convertible Debentures. It includes statements of utilization of issue proceeds, deviation or variation in use of proceeds, and an asset cover certificate. These disclosures are regulatory compliance filings related to debt instruments and their usage, not a full financial report or earnings release. The document is about ongoing compliance and reporting on debt instruments rather than a standalone audit report or annual report. It is not a report publication announcement since it contains substantive disclosure data. Therefore, the document fits best under the category of Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2023-02-14 English
In continuation of the Company's unaudited financial results (both standalone and consolidated) for the three and nine months ended December 31, 2022 ('the Results') filed with the stock ....
Interim / Quarterly Report Classification · 95% confidence The document is an Independent Auditor's Review Report on the unaudited interim financial results (both standalone and consolidated) for the three and nine months ended December 31, 2022. It references compliance with Indian Accounting Standard 34 (Interim Financial Reporting) and SEBI regulations for interim results. The content includes detailed auditor review procedures and conclusions on interim financial statements, which are characteristic of an Interim / Quarterly Report. The document is substantive and contains financial review content, not merely an announcement or certification. Therefore, it fits the category of an Interim / Quarterly Report (IR).
2023-02-14 English
Limited Review Report
Interim / Quarterly Report Classification · 95% confidence The document is an Independent Auditor's Review Report on the unaudited interim financial results (both standalone and consolidated) for the three and nine months ended December 31, 2022. It references Indian Accounting Standard 34 'Interim Financial Reporting' and SEBI regulations related to interim results. The document contains detailed auditor review procedures and conclusions on interim financial statements, indicating it is a review report on interim financial results. The length is substantial (15,000 characters) and contains substantive financial data and analysis, not merely an announcement or certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR).
2023-02-14 English
As per annexure enclosed
Interim / Quarterly Report Classification · 95% confidence The document is titled 'Earnings Update Q3 FY23' and contains detailed financial performance data for the third quarter of fiscal year 2023, including consolidated revenues, EBITDA, PAT, and segment-wise financials. It also includes clinical updates and highlights specific to the quarter. The presence of quarterly financial figures and operational highlights indicates this is a comprehensive interim financial report for a period shorter than a full fiscal year. The document length is substantial (15,000 characters), and it contains actual financial data and analysis rather than just an announcement or summary. Therefore, it fits the definition of an Interim / Quarterly Report (IR).
2023-02-14 English
Investor Presentation
Interim / Quarterly Report Classification · 95% confidence The document is titled 'Earnings Update Q3 FY23' and contains detailed financial performance data for the third quarter of fiscal year 2023, including consolidated revenues, EBITDA, PAT, and segment-wise financials. It also includes clinical updates and highlights specific to the quarter. The presence of quarterly financial figures and performance highlights indicates this is a comprehensive interim financial report for a period shorter than a full fiscal year. The document length is substantial (15,000 characters), and it contains actual financial data and analysis rather than just an announcement or summary. Therefore, it fits the definition of an Interim / Quarterly Report (IR).
2023-02-14 English
as per annexure enclosed
Interim / Quarterly Report Classification · 95% confidence The document is a detailed announcement from Apollo Hospitals Enterprise Limited regarding the outcome of a Board Meeting held on 14th February 2023. It includes unaudited financial results for the three and nine months ended 31st December 2022, which have been subjected to limited review by statutory auditors. It also declares an interim dividend for the financial year ending 31st March 2023, specifying the record date and payment date. The document contains substantive financial data including income, expenses, profit before tax, tax expenses, and comprehensive income for the interim period. The presence of unaudited financial results for a period shorter than a full fiscal year, along with detailed financial figures and analysis, indicates this is an Interim / Quarterly Report. It is not merely an announcement of a report or a certification, but contains actual financial statements and analysis. Therefore, the appropriate classification is Interim / Quarterly Report (IR).
2023-02-14 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.